I think we are having a retest of descending triangel and having a IH&S and getting to target 2.2kr.
Hi, Equinor ASA , an energy company, explores for, produces, transports, refines and markets petroleum and petroleum-derived products, and other forms of energy in Norway and internationally. Fundamental pros: 1. Trading below its fair value. 2. Good PE and PEG ratio. 3. Earnings are forecasted to grow. 4. A lot of insider buying. Technical pros: The...
Hi, Lerøy Seafood Group produces, processes, markets, and distributes fresh, frozen, and smoked seafood products in Norway. It shows pretty good value numbers, it is way undervalued, insiders (CEO) have bought the stock recently (actually yesterday) and etc. Fundamentally, Lerøy Seafood looks quite good and most importantly, technically as well. There is a ...
www.va.se finansavisen.no PCI Biotech OSL:PCIB is a biopharmaceutical company focusing on development and commercialisation of novel therapeutic solutions for improved treatment of cancer patients through its innovative photochemical internalisation (PCI) technology platform. PCI induces triggered endosomal release that can be used to unlock the...
Brokers Clarksons Platou covers Bonheur (17 Des), and sets objective at NOK 285. I have suggested both average support and resistance levels in red and blue, and the green upwards trend is self explaining. Holding medium sized position waiting for the (presumptive) January effect. If the objective is sound and realistic, there should still be plenty time to get aboard.
Bakkafrost looks to be closing to the top of everything, IF previous pattern repeats itself. From just half a year ago Bakkafrost could be bought at around 440 NOK followed by a steady rise to a current 640 NOK. This is a staggering 50% increase in just half a year. That alone is not the only factor Bakkafrost has against a further rise. We also see that if the...
BerGenBio OSL:BGBIO is a norwegian clinical-stage biopharmaceutical company focused on developing transformative drugs targeting AXL as a potential cornerstone of therapy for aggressive diseases, including immune-evasive, therapy resistant cancers. The stock is currently in a short term uptrend that could provide a new test of important resistance, where a...
Telenor is currently in a bearish trend, but it's nearing the area where one should look to buy. We have two significant horisontal supports. The first @ 156.75, and the second at 150.45. The logic game plan for me, is to place equal bids at the two levels. Making the potential average cost 153.6. TP 1: 180 (TP 2: 190)
NAS can get compensation from Boeing in 2019, will the stock break out of it falling pattern?
Just a short prediction while studying different kinds of patterns.
We've had some positive price development lately, and it looks like the trend is turning bullish. Golden cross MA50 above MA200 of course adds to our case. Current resistance is at 142.5....Interested in an entry @ 136.1 marked by the yellow line.
Entra hitting new all time highs, here's a possible way to ride the trend at a 6% risk, setting stops below the wick at the last weekly candle. Blackrock purchased stocks in Entra worth roughly $11m last week.
This consolidation will eventually end, and take a direction. The obvious play here is to buy here at the lower end of the consolidation. If this breaks out to the upside it can provide solid returns.
As we can see from the 1hr here, price bounced off support at 338 at decent volume. This indicates a switch in momentum to the north. I see resistance at 370 as the target price. But be aware that 200MA will probably provide some resistance first, since it has been well respected in this downtrend. NB: Entry, SL & TP is calculated from 338, price is now...
Some minor cypher predictions while reading about the stock.